Chronic Heart Failure Treatment With the Left Ventricular Assist Device
- Read the article. The test for this CE activity can only be taken online at www.NursingCenter.com/CE/HHN. Tests can no longer be mailed or faxed. You will need to create and login to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
- There is only one correct answer for each question.A passing score for this test is 14 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
- For questions, contact Lippincott Professional Development: 1-800-787-8985.
Registration Deadline: June 4, 2021
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Lippincott Professional Development will award 1.5 contact hours for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida #50-1223.
CE TEST QUESTIONS
To provide information about the mechanism, potential complications, and nursing implications of caring for patients who are using a left ventricular assist device.
After completing this continuing education activity, you should be able to:
- Describe the mechanism, indications, and contraindications for implantation of a left ventricular assist device.
- Explain the complications that can result from implantation of a left ventricular assist device.
- Plan the appropriate care for patients who have a left ventricular assist device.
- In recent years, the most common reason for implantation of a left ventricular assist device (LVAD) has become
- destination therapy.
- a bridge to cardiac transplant.
- a bridge to recovery in potentially reversible cardiac pathology.
- Compared with the first generation of LVAD devices, most LVADs implanted now
- are pulsatile.
- have a shorter lifespan.
- are continuous flow devices.
- Which of the following features of an LVAD represents the patient's cardiac output in liters per minute?
- the pump speed
- the pump flow
- the pulsatile index
- Which of the following is a function of the LVAD controller?
- collecting data about the system's operation
- pushing blood through a cannula in the aorta
- establishing a connection to the pump
- A patient who is eligible for implantation of an LVAD is expected to have
- an increased creatinine clearance level.
- a decreased blood urea nitrogen level.
- an increased B-type natriuretic peptide level.
- Which of the following disorders can make patients ineligible for implantation of an LVAD?
- diabetes mellitus
- Because patients with an LVAD are at risk for thrombosis, they require serial measurements of which of the following?
- C-reactive protein
- lactate dehydrogenase
- aspartate aminotransferase
- A common bacterial pathogen that can infect the percutaneous exit site of LVADs is
- Escherichia coli.
- Klebsiella pneumoniae.
- Pseudomonas aeruginosa.
- Because LVADs can cause thrombosis, patients require anticoagulation, with their international normalized ratio maintained between
- 0.5 and 1.5.
- 1.5 and 2.5.
- 2.5 and 3.5.
- A clinical manifestation of the complication of right ventricle failure following LVAD implantation is
- cool extremities.
- jugular vein distention.
- LVAD-induced ventricular dysrhythmias tend to occur as a result of
- preload excess.
- To measure blood pressure when assessing patients who have an LVAD, clinicians should use a
- traditional cuff and sphygmomanometer.
- Doppler blood pressure device.
- wrist blood pressure monitor.